Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 May;50(5):725-735.
doi: 10.1002/eji.201948318. Epub 2020 Feb 10.

CD8+ T cells mediate ultraviolet A-induced immunomodulation in a model of extracorporeal photochemotherapy

Affiliations
Free article

CD8+ T cells mediate ultraviolet A-induced immunomodulation in a model of extracorporeal photochemotherapy

Olivier Hequet et al. Eur J Immunol. 2020 May.
Free article

Abstract

Extracorporeal photochemotherapy (ECP) that takes advantage of the immunomodulatory effects of UV light has been extensively used for many years for the treatment of several T cell-mediated diseases, including graft-versus-host disease (GvHD) and systemic scleroderma. Immune mechanisms that lead to the establishment of T cell tolerance in ECP-treated patients remain poorly known. In this study, we have tested the effect of UV/psoralen-treated BM-derived dendritic cells, referred to as ECP-BMDCs on the outcome of an antigen-specific T cell-mediated reaction, that is, contact hypersensitivity (CHS), which is mediated by CD8+ effector T cells (CD8+ Teff ). The intravenous (i.v.) injection of antigen-pulsed ECP-BMDCs in recipient C57BL/6 mice induced specific CD8+ T cells endowed with immunomodulatory properties (referred to as CD8+ TECP ), which prevented the priming of CD8+ Teff and the development of CHS, independently of conventional CD4+ regulatory T cells. CD8+ TECP mediated tolerance by inhibiting the migration and functions of skin DC and subsequently the priming of CD8+ Teff . CD8+ TECP displayed none of the phenotypes of the usual CD8+ T regulatory cells described so far. Our results reveal an underestimated participation of CD8+ T cells to ECP-induced immunomodulation that could explain the therapeutic effects of ECP in T cell-mediated diseases.

Keywords: CD8+ regulatory T cells; T-cell priming; extracorporeal photochemotherapy; photopheresis; regulatory T cells.

PubMed Disclaimer

References

    1. Edelson, R., Berger, C., Gasparro, F., Jegasothy, B., Heald, P., Wintroub, B., Vonderheid, E. et al., Treatment of cutaneous T cell lymphoma by extracorporeal photochemotherapy: preliminary results. N. Engl. J. Med. 1987. 316: 297-303.
    1. Martino, M., Fedele, R., Cornelio, G., Moscato, T., Imbalzano, L., Ressa, G., Massara, E. et al., Extracorporeal photopheresis, a therapeutic option for cutaneous T-cell lymphoma and immunological diseases: state of the art. Expert Opin. Biol. Ther. 2012. 12: 1017-1030.
    1. Lamioni, A., Parisi, F., Isacchi, G., Giorda, E., Di Cesare, S., Landolfo, A., Cenci, F. et al., The immunological effects of extracorporeal photopheresis unraveled: induction of tolerogenic dendritic cells in vitro and regulatory T cells in vivo. Transplantation 2005. 79: 846-850.
    1. Perruche, S., Zahng, P., Liu, Y., Saas, P., Bluestone, JA. and Chen, W. CD3-specific antibody-induced immune tolerance involves transforming growth factor-β from phagocytes digesting apoptotic T cells. Nat. Med. 2008. 14: 528-535.
    1. Biaggi, E., Di Biaso, I., Leoni, V., Gaipa, G., Rossi, V., Bugarin, C., Renoldi, G. et al., Extracorporeal photochemotherapy is accompagnied by increasing levels of circulating CD4+CD25+GITR+FoxP3+CD62L+ functional regulatory T-cells in patients with graft-versus-host disease. Transplantation 2007. 84: 31-39.

Publication types

MeSH terms

LinkOut - more resources